Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 9, 2018
Characteristics and Outcome of ROS1-Positive Non-Small Cell Lung Cancer Patients in Routine Clinical PracticeSehhoon Park, Beung-Chul Ahn, Sung Won Lim, et al.
Therapeutic Advances in Medical Oncology|January 17, 2022
Predicting treatment outcomes using <sup>18</sup>F-FDG PET biomarkers in patients with non-small-cell lung cancer receiving chemoimmunotherapyChang Gon Kim, Sang Hyun Hwang, Kyung Hwan Kim, et al.
Cancers|February 24, 2024
Drug Response of Patient-Derived Lung Cancer Cells Predicts Clinical Outcomes of Targeted TherapySunshin Kim, Youngjoo Lee, Bo Ram Song, et al.
Scientific Reports|December 29, 2019
Patient-Derived Cells to Guide Targeted Therapy for Advanced Lung AdenocarcinomaSeok-Young Kim, Ji Yeon Lee, Dong Hwi Kim, et al.
Esophagus : Official Journal of the Japan Esophageal Society|December 25, 2025
Preoperative chemoradiotherapy plus pembrolizumab for esophageal squamous cell carcinoma (ACTS-29)Min Hee Hong, Sung Kwan Shin, Su-Jin Choi, et al.
JTO Clinical and Research Reports|December 2, 2024
Clinical Outcomes of Maintenance Durvalumab After Definitive Concurrent Chemoradiotherapy in Unresectable Locally Advanced Stage III NSCLC According to EGFR and ALK Status: Korean Cancer Study Group LU-22-18Dae-Ho Choi, Miso Kim, Young Saing Kim, et al.
European Journal of Cancer (Oxford, England : 1990)|December 10, 2020
Dynamic changes in circulating PD-1<sup>+</sup>CD8<sup>+</sup> T lymphocytes for predicting treatment response to PD-1 blockade in patients with non-small-cell lung cancerChang Gon Kim, Min Hee Hong, Kyung Hwan Kim, et al.
Nature Communications|December 27, 2024
A conserved pilin from uncultured gut bacterial clade TANB77 enhances cancer immunotherapyChan Yeong Kim, Dong Jin Park, Beung Chul Ahn, et al.
European Journal of Cancer (Oxford, England : 1990)|June 28, 2021
Clinical decision support algorithm based on machine learning to assess the clinical response to anti-programmed death-1 therapy in patients with non-small-cell lung cancerBeung-Chul Ahn, Jea-Woo So, Chun-Bong Synn, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 28, 2026
Consensus statement on ctDNA minimal residual disease (MRD) testing in early-stage NSCLC - A Delphi study by the Asian Thoracic Oncology Research Group (ATORG)Aaron C Tan, Bin-Chi Liao, Molly Li, et al.
Pageof 4